tiprankstipranks
Trending News
More News >
Silo Pharma (SILO)
NASDAQ:SILO
US Market
Advertisement

Silo Pharma (SILO) Income Statement

Compare
214 Followers

Silo Pharma Income Statement

Last quarter (Q2 2025), Silo Pharma's total revenue was $18.02K, a decrease of 0.00% from the same quarter last year. In Q2, Silo Pharma's net income was $-1.20M. See Silo Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 72.10K$ 72.10K$ 72.10K$ 71.26K$ 40.92K
Gross Profit
$ 66.26K$ 66.26K$ 66.26K$ 66.26K$ -135.20K
Operating Expenses
$ 4.77M$ 3.92M$ 3.69M$ 2.81M$ 2.27M
Depreciation and Amortization
$ 6.18K$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -4.38M$ -3.63M$ -3.91M$ 4.19M$ -2.39M
Operating Income
$ -4.71M$ -3.86M$ -3.63M$ -2.74M$ -2.20M
Other Income/Expenses
$ 312.81K$ 224.51K$ -279.73K$ 6.93M$ -464.55K
Pretax Income
$ -4.39M$ -3.63M$ -3.91M$ 4.18M$ -2.67M
Net Income
$ -4.39M$ -3.70M$ -3.91M$ 3.90M$ -3.04M
Per Share Metrics
Basic EPS
$ -1.19$ -1.20$ -1.71$ 1.32$ -2.35
Diluted EPS
$ -1.19$ -1.20$ -1.71$ 1.30$ -2.35
Weighted Average Shares Outstanding
3.68M 3.08M 2.28M 1.90M 1.32M
Weighted Average Shares Outstanding (Diluted)
3.68M 3.08M 2.28M 1.92M 1.32M
Currency in USD

Silo Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis